Growth Metrics

NovoCure (NVCR) Shareholder's Equity (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 52.06 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.98 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 49.20 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 10.33 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.96 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.67 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.20 Bn
10 NovoCure 1.90 Bn 1.47 Bn 135.13 Mn 330.72 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 330.72 Mn
Dec 31, 2025 340.47 Mn
Sep 30, 2025 341.33 Mn
Jun 30, 2025 349.44 Mn
Mar 31, 2025 361.96 Mn
Dec 31, 2024 360.18 Mn
Sep 30, 2024 360.78 Mn
Jun 30, 2024 361.75 Mn
Mar 31, 2024 359.36 Mn
Dec 31, 2023 362.50 Mn
Sep 30, 2023 393.70 Mn
Jun 30, 2023 415.68 Mn
Mar 31, 2023 432.15 Mn
Dec 31, 2022 441.17 Mn
Sep 30, 2022 445.40 Mn
Jun 30, 2022 441.67 Mn
Mar 31, 2022 435.88 Mn
Dec 31, 2021 410.49 Mn
Sep 30, 2021 413.16 Mn
Jun 30, 2021 397.27 Mn
Mar 31, 2021 372.13 Mn
Dec 31, 2020 476.53 Mn
Sep 30, 2020 307.04 Mn
Jun 30, 2020 267.82 Mn
Mar 31, 2020 241.95 Mn
Dec 31, 2019 217.79 Mn
Sep 30, 2019 190.37 Mn
Jun 30, 2019 158.91 Mn
Mar 31, 2019 126.39 Mn
Dec 31, 2018 112.26 Mn
Sep 30, 2018 114.94 Mn
Jun 30, 2018 112.08 Mn
Mar 31, 2018 106.12 Mn
Dec 31, 2017 113.56 Mn
Sep 30, 2017 116.69 Mn
Jun 30, 2017 117.55 Mn
Mar 31, 2017 128.90 Mn
Dec 31, 2016 142.35 Mn
Sep 30, 2016 158.24 Mn
Jun 30, 2016 186.65 Mn
Mar 31, 2016 220.43 Mn
Dec 31, 2015 250.82 Mn
Sep 30, 2015 121.22 Mn
Dec 31, 2014 97.88 Mn